We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Symantec (SYMC) Launches Norton 360 Deluxe in Microsoft Store
Read MoreHide Full Article
Symantec’s cyber safety brand — Norton LifeLock — recently announced the availability of Norton 360 Deluxe in the Microsoft (MSFT - Free Report) Store.
Reportedly, customers will now be able to download the software at a monthly subscription of $9.99, for both Windows 10 and Windows 10S, making it the first paid comprehensive cyber security product to be launched in Microsoft Store.
The Norton 360 Deluxe offers several features that help customers protect their personal information, including device security, online threat protection, smart firewall, PC cloud backup, secure VPN, password manager, PC SafeCam, parental control, virus protection promise and dark web monitoring.
Symantec’s partnership with Microsoft has been documented for about 25 years during which, Norton LifeLock developed more than 200 security solutions to secure and manage numerous desktops, laptops and servers running Windows and other Microsoft applications.
We note that Symantec acquired LifeLock in fiscal 2017, at a time when Norton’s sales were falling with decline in the PC market. Even though the acquisition did not have any material impact in fiscal 2017 and fiscal 2018, it contributed to the 3% year-over-year growth in the Consumer Cyber Safety segment during fiscal 2019. During the fiscal year, the company drove significant market adoption and high customer retention of the Consumer Cyber Safety solutions on the back of the Norton LifeLock product portfolio.
Despite the efforts, competition remains strong for Norton Security. The brand faces significant competition from Avast Software, McAfee, Kaspersky and Trend Micro (TMICY - Free Report) .
Moreover, Microsoft’s own suite of desktop security solutions, Microsoft Managed Desktop, is also a concern for Norton’s share in the desktop security market.
Further, the persistent sluggishness in the PC Market is a major headwind to Norton’s sales.
However, the continued efforts to upgrade and improve the brand is expected to keep Symantec ahead in the cybersecurity market.
Long-term earnings growth for eGain is projected to be 30%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Symantec (SYMC) Launches Norton 360 Deluxe in Microsoft Store
Symantec’s cyber safety brand — Norton LifeLock — recently announced the availability of Norton 360 Deluxe in the Microsoft (MSFT - Free Report) Store.
Reportedly, customers will now be able to download the software at a monthly subscription of $9.99, for both Windows 10 and Windows 10S, making it the first paid comprehensive cyber security product to be launched in Microsoft Store.
The Norton 360 Deluxe offers several features that help customers protect their personal information, including device security, online threat protection, smart firewall, PC cloud backup, secure VPN, password manager, PC SafeCam, parental control, virus protection promise and dark web monitoring.
Symantec’s partnership with Microsoft has been documented for about 25 years during which, Norton LifeLock developed more than 200 security solutions to secure and manage numerous desktops, laptops and servers running Windows and other Microsoft applications.
We note that Symantec acquired LifeLock in fiscal 2017, at a time when Norton’s sales were falling with decline in the PC market. Even though the acquisition did not have any material impact in fiscal 2017 and fiscal 2018, it contributed to the 3% year-over-year growth in the Consumer Cyber Safety segment during fiscal 2019. During the fiscal year, the company drove significant market adoption and high customer retention of the Consumer Cyber Safety solutions on the back of the Norton LifeLock product portfolio.
Symantec Corporation Revenue (TTM)
Symantec Corporation revenue-ttm | Symantec Corporation Quote
Challenges to Norton
Despite the efforts, competition remains strong for Norton Security. The brand faces significant competition from Avast Software, McAfee, Kaspersky and Trend Micro (TMICY - Free Report) .
Moreover, Microsoft’s own suite of desktop security solutions, Microsoft Managed Desktop, is also a concern for Norton’s share in the desktop security market.
Further, the persistent sluggishness in the PC Market is a major headwind to Norton’s sales.
However, the continued efforts to upgrade and improve the brand is expected to keep Symantec ahead in the cybersecurity market.
Zacks Rank & A Key Pick
Symantec currently has a Zacks Rank #3 (Hold).
A better-ranked stock in the broader Computer and Technology sector is eGain Corporation (EGAN - Free Report) , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Long-term earnings growth for eGain is projected to be 30%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>